Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry. It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These ap...
Saved in:
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2012.
|
| Edition: | 1st ed. 2012. |
| Series: | SpringerBriefs in Pharmaceutical Science & Drug Development,
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-1-4614-3682-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|